Conference
A randomized phase II clinical trial of the SRC inhibitor saracatinib (AZD0530) and carboplatin plus paclitaxel (C plus P) versus C plus P in patients (pts) wiht advanced platinum-sensitive epithelial ovarian cancer (eoc)
العنوان: | A randomized phase II clinical trial of the SRC inhibitor saracatinib (AZD0530) and carboplatin plus paclitaxel (C plus P) versus C plus P in patients (pts) wiht advanced platinum-sensitive epithelial ovarian cancer (eoc) |
---|---|
المؤلفون: | Poole, Christopher J., Lisyanskaya, A., Rodenhuis, S., Kristensen, G., Lauraine, E. Pujade, Cantarini, M., Emeribe, U., Stuart, M., Coquard, I. Ray |
بيانات النشر: | Oxford University Press |
سنة النشر: | 2010 |
المجموعة: | The University of Warwick: WRAP - Warwick Research Archive Portal |
مصطلحات موضوعية: | RC0254 Neoplasms. Tumors. Oncology (including Cancer) |
نوع الوثيقة: | conference object |
اللغة: | unknown |
Relation: | Poole, Christopher J., Lisyanskaya, A., Rodenhuis, S., Kristensen, G., Lauraine, E. Pujade, Cantarini, M., Emeribe, U., Stuart, M. and Coquard, I. Ray (2010) A randomized phase II clinical trial of the SRC inhibitor saracatinib (AZD0530) and carboplatin plus paclitaxel (C plus P) versus C plus P in patients (pts) wiht advanced platinum-sensitive epithelial ovarian cancer (eoc). In: 35th European-Society-for-Medical-Oncology (ESMO) Congress, Milan, Italy, 8-12 Oct 2010. Published in: Annals of Oncology, Volume 21 (Supplement 8). pp. 304-305. ISSN 0923-7534. |
الاتاحة: | https://wrap.warwick.ac.uk/id/eprint/4568/ |
رقم الانضمام: | edsbas.7F4E4C52 |
قاعدة البيانات: | BASE |
الوصف غير متاح. |